HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Toshifumi Murashita Yasuhiro Kamikubo Keishu Yasuda Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murashita, T. Articles by Yasuda, K. Search for Related Content PubMed PubMed Citation Articles by Murashita, T. Articles by Yasuda, K. Related Collections Valve disease

Eur J Cardiothorac Surg 2004;26:1104-1111
© 2004 Elsevier Science NL

Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes

Department of Cardiovascular Surgery, Hokkaido University Graduate School of Medicine, Kita 14, Nishi-5, Kita-Ku, Sapporo 060-8648, Japan

Received 11 June 2004; received in revised form 23 July 2004; accepted 2 August 2004.

^* Corresponding author. Tel.: +80 11 716 1161x6042; fax: +81 11 747 0476. (E-mail: muratosh{at}med.hokudai.ac.jp).

Objective: Surgical treatment of active infective endocarditis requires not only hemodynamic repair, but also special emphasis on the eradiation of the infectious focus to prevent recurrence. This goal can be achieved by the combination of aggressive debridement of infective tissue and appropriate and adequate antibiotic treatment. We reviewed our experience with active endocarditis and identified factors determining early and late outcomes, particularly focusing on the factor of culture-negative endocarditis. Methods: Sixty seven patients with clinical evidence of active endocarditis who underwent operation between 1991 and 2001 were evaluated. The aortic valve was infected in 28 (42%), the mitral valve in 23 (34%), and multiple valves in 16 (24%). Native valve endocarditis was present in 58 (87%) and prosthetic valve endocarditis in 9 (13%). Mean follow-up was 5.7 years (range, 0.2–11.5 years). Results: Microorganisms were detected in 46 (69%): Staphylococcus aureus in 9 (13%), other staphylococci in 9 (13%), streprococcus species in 19 (28%), and others in 9 (28%), whereas 21 (31%) patients had culture-negative endocarditis. Operative mortality was 17.8% (12 patients). Reoperation was required in 8 (12%), while 3 late deaths (5.5% of hospital survivors) occurred. All events, including death, reoperation, periprosthetic leak, and recurrence of infection, occurred within 2 years after operation. Actuarial freedom from reoperation, late survival, and events at 5 years were 81.6, 76.4, and 68.6%, respectively. On multivariate analysis, no independent adverse predictor was detected for hospital death, whereas the following independent adverse predictors were identified: preoperative heart failure (P=0.0375), prosthetic valve endocarditis (P=0.0391) and culture-negative endocarditis (P=0.0354) for poor late survival; culture-negative endocarditis (P=0.0354) and annular abscess (P=0066) for poor event-free suvival. Freedom from events was similar between patients with Staphylococcus aureus infection (3-year freedom 55.6%) and culture-negative endocarditis (3-year freedom 47.6%), whereas events were significantly low in patients with streptococcus infection (3-year freedom 100%). Conclusions: In our analysis, no independent adverse predictor was detected for hospital death; however, culture-negative endocarditis was identified as an independent predictor for both late survival and events after surgery. Event-free survivals were similar between staphylococcus infection and culture-negative endocarditis, and all events occurred within 2 years after operation, suggesting the necessity of close follow-up during that period.

This article has been cited by other articles:

				S. Lehmann, T. Walther, S. Leontyev, J. Kempfert, J. Garbade, M. A. Borger, and F. W. Mohr The Toronto Root Bioprosthesis: Midterm Results in 186 Patients. Ann. Thorac. Surg., June 1, 2009; 87(6): 1751 - 1756. [Abstract] [Full Text] [PDF]

				J. Lopez, A. Revilla, I. Vilacosta, E. Villacorta, C. Gonzalez-Juanatey, I. Gomez, M. J. Rollan, and J. A. San Roman Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis Eur. Heart J., March 2, 2007; 28(6): 760 - 765. [Abstract] [Full Text] [PDF]

				O. Adam, T. Kramm, H. H. Klein, and H.-J. Schafers Intraaortic Vegetations as a Manifestation of Infective Endocarditis N. Engl. J. Med., February 22, 2007; 356(8): 874 - 875. [Full Text] [PDF]